All Disease Treatment & Prevention articles – Page 4
-
NewsEleven genetic variants affect the gut microbiome
In two new studies on 28,000 individuals, researchers are able to show that genetic variants in 11 regions of the human genome have a clear influence on which bacteria are in the gut and what they do there. Only two genetic regions were previously known.
-
NewsBasic research on Listeria bacteria leads to unique cancer therapy
After nearly 40 years of research on how Listeria bacteria manipulate our cells and battle our immune system to cause listeriosis, researchers have discovered a way to turn the bacteria into a potent booster of the immune system — and a potential weapon against cancer.
-
NewsChildren with Crohn’s have distinct gut bacteria from kids with other digestive disorders
Researchers have found a “microbial signature” of pediatric Crohn’s disease that differs from the makeup of gut bacteria in children with other gastrointestinal conditions, with Crohn’s patients harboring more pro-inflammatory bacteria and less protective bacteria.
-
NewsResearchers solve mystery behind rare clotting after adenoviral vaccines or natural adenovirus infection
Scientists have uncovered why a small number of people developed dangerous blood clots after either receiving certain COVID‑19 vaccines or experiencing a natural adenovirus infection - the answer lies in an unexpected case of misdirected targeting by the immune system.
-
NewsVirus-based therapy boosts anti-cancer immune responses to brain cancer
A study has shown that a single injection of an oncolytic virus—a genetically modified virus that selectively infects and destroys cancer cells—can recruit immune cells to penetrate and persist deep within brain tumors.
-
NewsLong COVID linked to Alzheimer’s disease mechanisms
The increased size of, and lesser blood supply to, a key brain structure in patients with Long COVID tracks with known blood markers of Alzheimer’s disease and greater levels of dementia, a new study finds.
-
News‘Hidden’ bugs in our gut appear key to good health, finds global study
A single group of bacteria has repeatedly shown up in high numbers in the gut microbiomes of healthy people. Scientists found the level of CAG-170 bacteria present was consistently higher in healthy people than those with diseases including inflammatory bowel disease, obesity and chronic fatigue syndrome.
-
NewsWhat drives food allergies? New study pinpoints early-life factors that raise risk - including microbiome
A new study involving 2.8 million children around the world has revealed the most important early-life factors that influence whether a child becomes allergic to food. Genetics alone cannot fully explain food allergy trends, pointing to interactions between genes, skin health, the microbiome, and environmental exposures.
-
NewsScientists uncover link between influenza and heart disease
Researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk of a heart attack or other major cardiovascular event.
-
NewsNew study: Immune cells linked to Epstein-Barr virus may play a role in MS
Researchers have found that certain types of CD8+ “killer” T cells — immune cells that destroy damaged or infected cells — are more abundant in people with MS. Some of these killer T cells target EBV, which suggests that the virus may trigger the damaging immune response seen in MS.
-
NewsYeast cells can be used for rapid testing of cancer immunotherapy
An international research team has developed a new yeast-based biotechnological platform that makes it possible to test and understand advanced cancer treatments much faster and cheaper than before. It can reduce development time for new types of cancer immunotherapy from months to days or weeks.
-
NewsResearchers urge focus on child obesity and gut health to reduce risk of diabetes
Researchers are calling for more study of obesity, gut bacteria and metabolic conditions that arise in childhood and adolescence, with an eye to curbing the global rise of type 2 diabetes.
-
News A fungus living in our body can make melanoma more aggressive
A study has for the first time established the mechanism by means of which the Candida albicans fungus makes melanoma more aggressive. It activates several signalling pathways in the melanoma cells, creating an environment that helps to reprogram angiogenesis and metabolism.
-
NewsCommon bacteria discovered in the eye linked to cognitive decline
Chlamydia pneumoniae can linger in the eye and brain for years and may aggravate Alzheimer’s disease. Research suggests this bacterium can amplify Alzheimer’s disease and points to potential interventions including inflammation-limiting therapies and early antibiotic treatment.
-
NewsVaping zebrafish suggest E-cigarette exposure disrupts gut microbial networks and neurobehavior
Researchers hope to spark broader public discussion on the health risks of e-cigarettes and provide scientific evidence to support a reassessment of existing regulations.
-
NewsHow bacteria in the mouth may offer new clues to cognitive dysfunction in people with schizophrenia
An association between oral microbiota and cognitive performance in schizophrenia has been reported by researchers. The study shows that lower oral microbial diversity is associated with poorer cognitive function, with specific predicted microbial metabolic pathways potentially linked to this relationship.
-
NewsNatural sunscreen compounds show potential to support skin health and blood pressure
Researchers have discovered that natural ‘sunscreen’ compounds found in algae and cyanobacteria may also support skin and heart health.
-
NewsSepsis study IDs simple ways to save lives in Africa
Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a new study reveals. It found that more than half of the hundreds of patients enrolled in the study had TB and that immediate treatment increased their chances of survival significantly.
-
NewsFecal microbiota transplantation improves response to immunotherapy in advanced kidney cancer
A new study provides compelling evidence that fecal microbiota transplantation (FMT) can enhance the effectiveness of immunotherapy in patients with advanced metastatic renal cell carcinoma (mRCC).
-
NewsInnovative ‘poop pills’ show promising results in clinical trials for multiple types of cancer
Fecal microbiota transplants (FMT), can dramatically improve cancer treatment. One study shows that the toxic side effects of drugs to treat kidney cancer could be eliminated with FMT. A second suggests FMT is effective in improving the response to immunotherapy in patients with lung cancer and melanoma.